Jim Simons Prometheus Biosciences, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$103.46 - $126.29 $134,498 - $164,177
1,300 Added 0.54%
243,875 $26.2 Million
Q4 2022

Feb 13, 2023
BUY
$36.06 - $117.21 $4.77 Million - $15.5 Million
132,300 Added 119.97%
242,575 $26.7 Million
Q3 2022

Nov 14, 2022
BUY
$28.17 - $59.01 $1.71 Million - $3.58 Million
60,675 Added 122.33%
110,275 $6.51 Million
Q2 2022

Aug 12, 2022
BUY
$22.39 - $38.94 $1.11 Million - $1.93 Million
49,600 New
49,600 $1.4 Million

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email